OPPENHEIMER & CO INC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 93 filers reported holding IMMUNOMEDICS INC in Q1 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$468,000
+25.8%
5,500
-47.6%
0.01%
+20.0%
Q2 2020$372,000
+210.0%
10,500
-68.0%
0.01%
+233.3%
Q4 2016$120,000
+12.1%
32,7700.0%0.00%0.0%
Q3 2016$107,000
+67.2%
32,770
+18.0%
0.00%
+50.0%
Q2 2016$64,000
-22.9%
27,770
-15.9%
0.00%
-33.3%
Q1 2016$83,000
-26.5%
33,020
-10.2%
0.00%0.0%
Q4 2015$113,000
+145.7%
36,770
+37.4%
0.00%
+200.0%
Q3 2015$46,000
-87.8%
26,770
-71.2%
0.00%
-90.0%
Q2 2015$377,000
-23.7%
92,826
-28.0%
0.01%
-23.1%
Q1 2015$494,000
-40.0%
129,004
-24.8%
0.01%
-45.8%
Q4 2014$824,000
+66.5%
171,548
+28.8%
0.02%
+60.0%
Q3 2014$495,000
+29.6%
133,160
+27.0%
0.02%
+36.4%
Q2 2014$382,000
-2.6%
104,810
+12.4%
0.01%
-8.3%
Q1 2014$392,000
-1.5%
93,210
+7.9%
0.01%
-7.7%
Q4 2013$398,000
-5.7%
86,370
+26.7%
0.01%
-13.3%
Q3 2013$422,000
-14.2%
68,170
-24.5%
0.02%
-21.1%
Q2 2013$492,00090,3200.02%
Other shareholders
IMMUNOMEDICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders